Developer docs
API playgroundTry for free, no card

Search company profiles

Tuteur Group

Full company profile

uuid0038dse

Namestring
Tuteur Group
Legal namestring
Tuteur S.A.C.I.F.I.A.
Websiteurl
tuteurgroup.com
Company typeenum
Private
Founded yearint
1972
Descriptiontext

Tuteur Group (legal entity Tuteur S.A.C.I.F.I.A.) is an Argentine pharmaceutical laboratory founded in 1972 in Luján, Buenos Aires, that develops, manufactures, and commercializes specialty pharmaceutical products for high-complexity and rare diseases. The company operates two cGMP-compliant production plants in Argentina — the original Luján site and a segregated oral solid dose plant inaugurated in Buenos Aires in 2012, supplemented by the Victoria non-segregated plant acquired in 2019 — totaling 7,500 square meters of production capacity. Its 140-product portfolio spans oncology, neurology, nephrology, autoimmune, biotherapeutic, pulmonology, hematology, and rare diseases, with a stated emphasis on orphan and low-incidence conditions.

Tuteur commercializes products through a sales-led, enterprise field model with direct commercial operations across 9 Latin American countries and export relationships into Europe (active since 1980). The Medical Science Liaison (MSL) team supports physicians with scientific collaboration and access facilitation, while the Programa Puentes patient support program provides direct engagement with patients on Tuteur therapies. A track-and-trace order platform serves institutional clients.

The company is family-controlled into its third generation of pharmacists, led by President Jonathan Hahn, and became fully independent in 2011 after acquiring Teva Pharmaceutical Industries' stake in the former Teva-Tuteur joint venture (formed 1992). With approximately 700 employees and an average of 55 new product registrations annually across Latin American regulatory regimes, Tuteur positions itself as a regional pioneer in rare-disease specialty pharmaceuticals.

Short descriptiontext

Tuteur Group is an Argentine pharmaceutical laboratory founded in 1972 that manufactures and distributes a 140-product specialty portfolio for high-complexity and rare diseases across 9 Latin American countries, operating two cGMP plants in Argentina.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBuenos Aires, Argentina
HQ citystring
Buenos Aires
HQ countrystring
Argentina
HQ regionstring
Latin America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, rare disease therapeutics, oncology medications, pharmaceutical manufacturing, cGMP drug production
Industry2 codes
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing32541
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceuticals
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Products
TypeOne Time License
Description

Development, elaboration and commercialization of pharmaceutical products across Latin America and the world, focusing on high complexity diseases.

tuteurgroup.com
2Medical Food Products
TypeOne Time License
Description

Commercialization of foods for specific medical purposes.

tuteurgroup.com
3Food Industry Inputs
TypeOne Time License
Description

Commercialization and distribution of inputs for the food industry from international companies.

tuteurgroup.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Tuteur Group develops, manufactures, and commercializes specialty pharmaceutical products targeting high-complexity and rare diseases — including oncology, neurology, nephrology, autoimmune, hematology, and orphan disease therapeutics. The company operates two cGMP-compliant manufacturing plants in Argentina and distributes its 140-product portfolio through its own commercial offices in 9 Latin American countries plus international export channels. It supplements product sales with patient support (Programa Puentes), physician scientific liaison services (MSL), and digital order tracking.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 140 products in portfolio across Latin America
+2 more records
Product overview1 text field

Tuteur Group is a pharmaceutical laboratory with over 50 years of experience specializing in the development, production, and commercialization of pharmaceutical products for high-complexity diseases. The company operates two production plants in Argentina and distributes products across Latin America. The product portfolio is organized into therapeutic categories including: Oncology (with 40+ products such as ZANTERIB®/Cabozantinib, PACLITAXEL TUTEUR®, METAPLATIN®/Oxaliplatino), Neurology (with products like TILMURATO®/Dimetilfumarato, OSPOLOT®/Sultiame, KYMONOD®/Siponimod), Nephrology (including TOLKISTAN®/Tolvaptan, TENALCET®/Cinacalcet, FOSEVA®/Sevelamer Carbonato), and Rare Diseases (such as ORPHACOL®/Ácido Cólico, CARBAGLU®). The company also provides patient support services through its Programa Puentes, Medical Science Liaison (MSL) services, and a customer order tracking system. With 140 products in portfolio, 700 collaborators, and operations in 9 Latin American countries, Tuteur positions itself as a pioneer in rare and high-complexity diseases, offering both specialized pharmaceuticals and patient support services.

Product and service2 records
1AGACEL® (Imatinib)
CategoryPharmaceutical - Oncology
Description

Oncology medication for the treatment of malignancies including chronic myeloid leukemia. Targeted at specialist oncologists and healthcare providers treating leukemia patients.

2ZANTERIB® (Cabozantinib)
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on1992-01-01
Description

Joint venture Teva-Tuteur established in 1992 with Teva, the world's largest generic pharmaceutical company. In 2011, Tuteur acquired Teva's participation to become 100% Tuteur. The partnership enabled market expansion and technology transfer in generic pharmaceuticals.

Strategic tierMinorTypeOthers
Description

Commercialization and distribution of inputs for the food industry from international companies, including dairy and wine industry products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Gador
TypeDirect peer
Description

Argentine pharmaceutical laboratory with proprietary manufacturing and a specialty pharma portfolio spanning oncology, neurology, and other high-complexity areas. Comparable size and Latin American orientation to Tuteur.

2Laboratorios Roemmers
TypeDirect peer
Description

Large Argentine pharmaceutical group with proprietary manufacturing and broad specialty prescription portfolio across LATAM. Direct peer on Argentine-pharma-specialty axis with similar 9-country-ish reach.

TypeBroad incumbent
Description

World's largest generic pharmaceutical company and former JV partner of Tuteur (Teva-Tuteur, 1992–2011). Competes head-to-head in generic oncology, neurology, and nephrology molecules in LATAM.

TypeEmerging player
Description

LATAM-focused specialty pharma with presence in rare diseases, specialty therapeutics, and biopharmaceuticals across multiple Latin American markets. Comparable emerging regional player targeting similar specialty/rare-disease positioning.

5Laboratorios Casasco
TypeDirect peer
Description

Argentine pharmaceutical laboratory with specialty prescription focus across therapeutic categories, including central nervous system and oncology. Comparable Argentine specialty-pharma footprint.

6Laboratorio Raffo
TypeDirect peer
Description

Argentine specialty pharma with own manufacturing and oncology, neurology and rare-disease presence in LATAM. Closely comparable business model and therapeutic mix to Tuteur.

TypeDirect peer
Description

Argentine-headquartered specialty pharmaceutical group with manufacturing and broad LATAM distribution across therapeutic areas including oncology, neurology, and rare diseases. Closest comparable in scale, geography, and therapeutic mix to Tuteur Group.

8Eurofarma Laboratórios
TypeBroad incumbent
Description

Largest Brazilian-owned pharmaceutical company with own cGMP manufacturing, broad specialty and generic portfolio, and presence across LATAM. Larger and broader incumbent operating in overlapping specialty and rare-disease segments.

9Sandoz (Novartis)
TypeBroad incumbent
Description

Global generic and biosimilar leader with significant LATAM presence. Directly competes with Tuteur's generic oncology and specialty molecules across the region.

TypeBroad incumbent
Description

Major Brazilian pharmaceutical company with own manufacturing, oncology and specialty prescription products, and regional LATAM reach. Larger-scale LATAM specialty pharma comparable to Tuteur.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tuteur Group

Specialty Pharmaceuticalstuteurgroup.com

Tuteur Group is an Argentine pharmaceutical laboratory founded in 1972 that manufactures and distributes a 140-product specialty portfolio for high-complexity and rare diseases across 9 Latin American countries, operating two cGMP plants in Argentina.

What Tuteur Group does

Tuteur Group (legal entity Tuteur S.A.C.I.F.I.A.) is an Argentine pharmaceutical laboratory founded in 1972 in Luján, Buenos Aires, that develops, manufactures, and commercializes specialty pharmaceutical products for high-complexity and rare diseases. The company operates two cGMP-compliant production plants in Argentina — the original Luján site and a segregated oral solid dose plant inaugurated in Buenos Aires in 2012, supplemented by the Victoria non-segregated plant acquired in 2019 — totaling 7,500 square meters of production capacity. Its 140-product portfolio spans oncology, neurology, nephrology, autoimmune, biotherapeutic, pulmonology, hematology, and rare diseases, with a stated emphasis on orphan and low-incidence conditions.

Tuteur commercializes products through a sales-led, enterprise field model with direct commercial operations across 9 Latin American countries and export relationships into Europe (active since 1980). The Medical Science Liaison (MSL) team supports physicians with scientific collaboration and access facilitation, while the Programa Puentes patient support program provides direct engagement with patients on Tuteur therapies. A track-and-trace order platform serves institutional clients.

The company is family-controlled into its third generation of pharmacists, led by President Jonathan Hahn, and became fully independent in 2011 after acquiring Teva Pharmaceutical Industries' stake in the former Teva-Tuteur joint venture (formed 1992). With approximately 700 employees and an average of 55 new product registrations annually across Latin American regulatory regimes, Tuteur positions itself as a regional pioneer in rare-disease specialty pharmaceuticals.

Tuteur Group firmographics

Firmographics
Name
Tuteur Group
Legal name
Tuteur S.A.C.I.F.I.A.
Website
https://tuteurgroup.com
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Tuteur Group is an Argentine pharmaceutical laboratory founded in 1972 that manufactures and distributes a 140-product specialty portfolio for high-complexity and rare diseases across 9 Latin American countries, operating two cGMP plants in Argentina.
Ownership category
akta.pro rank

Tuteur Group industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Specialty pharmaceuticals
  • Rare disease therapeutics
  • Oncology medications
  • Pharmaceutical manufacturing
  • CGMP drug production

Where Tuteur Group is headquartered

Location

Headquarters

HQ city
Buenos Aires
HQ country
Argentina
HQ region
Latin America

Offices5 records

Markets served

Tuteur Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Products: Development, elaboration and commercialization of pharmaceutical products across Latin America and the world, focusing on high complexity diseases.
  2. Medical Food Products: Commercialization of foods for specific medical purposes.
  3. Food Industry Inputs: Commercialization and distribution of inputs for the food industry from international companies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Tuteur Group product offering

Product offering

Core offering

Tuteur Group develops, manufactures, and commercializes specialty pharmaceutical products targeting high-complexity and rare diseases — including oncology, neurology, nephrology, autoimmune, hematology, and orphan disease therapeutics. The company operates two cGMP-compliant manufacturing plants in Argentina and distributes its 140-product portfolio through its own commercial offices in 9 Latin American countries plus international export channels. It supplements product sales with patient support (Programa Puentes), physician scientific liaison services (MSL), and digital order tracking.

Product overview

Tuteur Group is a pharmaceutical laboratory with over 50 years of experience specializing in the development, production, and commercialization of pharmaceutical products for high-complexity diseases. The company operates two production plants in Argentina and distributes products across Latin America. The product portfolio is organized into therapeutic categories including: Oncology (with 40+ products such as ZANTERIB®/Cabozantinib, PACLITAXEL TUTEUR®, METAPLATIN®/Oxaliplatino), Neurology (with products like TILMURATO®/Dimetilfumarato, OSPOLOT®/Sultiame, KYMONOD®/Siponimod), Nephrology (including TOLKISTAN®/Tolvaptan, TENALCET®/Cinacalcet, FOSEVA®/Sevelamer Carbonato), and Rare Diseases (such as ORPHACOL®/Ácido Cólico, CARBAGLU®). The company also provides patient support services through its Programa Puentes, Medical Science Liaison (MSL) services, and a customer order tracking system. With 140 products in portfolio, 700 collaborators, and operations in 9 Latin American countries, Tuteur positions itself as a pioneer in rare and high-complexity diseases, offering both specialized pharmaceuticals and patient support services.

Differentiator

Problem solved

Functional benefit

Products and services

  • AGACEL® (Imatinib) Oncology medication for the treatment of malignancies including chronic myeloid leukemia. Targeted at specialist oncologists and healthcare providers treating leukemia patients.
  • ZANTERIB® (Cabozantinib)

Quantifiable outcome

  • 140 products in portfolio across Latin America
  • +2 more outcomes

Companies that use Tuteur Group

Customer profile

Segments3 records

Ideal customer profiles2 records

Tuteur Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Tuteur Group partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major and minor.

  • Teva Pharmaceutical IndustriesmajorStrategic or Co-development Partner · 1 January 1992Joint venture Teva-Tuteur established in 1992 with Teva, the world's largest generic pharmaceutical company. In 2011, Tuteur acquired Teva's participation to become 100% Tuteur. The partnership enabled market expansion and technology transfer in generic pharmaceuticals.
  • International Food Industry SuppliersminorOthersCommercialization and distribution of inputs for the food industry from international companies, including dairy and wine industry products.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Tuteur Group competitors and assessment

Company assessment

Direct peers

  • Gador: Argentine pharmaceutical laboratory with proprietary manufacturing and a specialty pharma portfolio spanning oncology, neurology, and other high-complexity areas. Comparable size and Latin American orientation to Tuteur.
  • Laboratorios Roemmers: Large Argentine pharmaceutical group with proprietary manufacturing and broad specialty prescription portfolio across LATAM. Direct peer on Argentine-pharma-specialty axis with similar 9-country-ish reach.
  • Laboratorios Casasco: Argentine pharmaceutical laboratory with specialty prescription focus across therapeutic categories, including central nervous system and oncology. Comparable Argentine specialty-pharma footprint.
  • Laboratorio Raffo: Argentine specialty pharma with own manufacturing and oncology, neurology and rare-disease presence in LATAM. Closely comparable business model and therapeutic mix to Tuteur.
  • Laboratorios Bagó: Argentine-headquartered specialty pharmaceutical group with manufacturing and broad LATAM distribution across therapeutic areas including oncology, neurology, and rare diseases. Closest comparable in scale, geography, and therapeutic mix to Tuteur Group.

Broad incumbents

  • Teva Pharmaceutical Industries: World's largest generic pharmaceutical company and former JV partner of Tuteur (Teva-Tuteur, 1992–2011). Competes head-to-head in generic oncology, neurology, and nephrology molecules in LATAM.
  • Eurofarma Laboratórios: Largest Brazilian-owned pharmaceutical company with own cGMP manufacturing, broad specialty and generic portfolio, and presence across LATAM. Larger and broader incumbent operating in overlapping specialty and rare-disease segments.
  • Sandoz (Novartis): Global generic and biosimilar leader with significant LATAM presence. Directly competes with Tuteur's generic oncology and specialty molecules across the region.
  • Aché Laboratórios: Major Brazilian pharmaceutical company with own manufacturing, oncology and specialty prescription products, and regional LATAM reach. Larger-scale LATAM specialty pharma comparable to Tuteur.

Emerging players

  • Biopas: LATAM-focused specialty pharma with presence in rare diseases, specialty therapeutics, and biopharmaceuticals across multiple Latin American markets. Comparable emerging regional player targeting similar specialty/rare-disease positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Tuteur Group social profiles

Digital presence

Tuteur Group compliance and trust

Trust signal

Compliance1 record

Tuteur Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tuteur Group leadership team

Management profile

Number of profiles

Profiles1 record

Tuteur Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tuteur Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tuteur Group

What does Tuteur Group do?

Tuteur Group develops, manufactures, and commercializes specialty pharmaceutical products targeting high-complexity and rare diseases — including oncology, neurology, nephrology, autoimmune, hematology, and orphan disease therapeutics. The company operates two cGMP-compliant manufacturing plants in Argentina and distributes its 140-product portfolio through its own commercial offices in 9 Latin American countries plus international export channels. It supplements product sales with patient support (Programa Puentes), physician scientific liaison services (MSL), and digital order tracking.

Is Tuteur Group a public or private company?

Tuteur Group is a private company. It is classified as family owned and is currently operating.

When was Tuteur Group founded?

Tuteur Group was founded in 1972. It employs 501 to 1,000 people.

Where is Tuteur Group based?

Tuteur Group is headquartered in Buenos Aires, Argentina, in the Latin America region.

How does Tuteur Group make money?

Three revenue lines are on record. Pharmaceutical Products are the primary driver. The others are medical Food Products and food Industry Inputs.

Who are Tuteur Group's main competitors?

Direct peers on record are Gador, Laboratorios Roemmers, Laboratorios Casasco, Laboratorio Raffo and Laboratorios Bagó. Broad incumbents are Teva Pharmaceutical Industries, Eurofarma Laboratórios, Sandoz (Novartis) and Aché Laboratórios. Biopas is listed as an emerging player.

Does Tuteur Group have an API?

No public API is recorded for Tuteur Group.

What industry is Tuteur Group in?

Tuteur Group's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAIAJAL, Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals